首页 | 本学科首页   官方微博 | 高级检索  
     检索      

多西他赛联合顺铂治疗进展期非小细胞肺癌的疗效观察
引用本文:张来莎,褚金华.多西他赛联合顺铂治疗进展期非小细胞肺癌的疗效观察[J].长江大学学报,2009,6(3):90-91.
作者姓名:张来莎  褚金华
作者单位:江汉油田总医院药学部;
摘    要:目的:探讨多西他赛加顺铂治疗进展期非小细胞肺癌的疗效和毒副反应。方法:选取初治进展期非小细胞肺癌17例,应用多西他赛加顺铂方案化疗,观察化疗毒副反应,2周期后评价疗效。结果:2组的近期有效率分别为52.9%和42.3%,无显著性差异(χ2=0.467,P=0.494)。2组间Ⅲ、Ⅳ度毒副反应多西他赛组有2例患者出现严重液潴留。结论:多西他赛联合顺铂治疗非小细胞肺癌疗效好,但其副作用较重,可致体液潴留,应用多西他赛时需强调化疗前的激素足量、化疗后的病情监测和发生体液潴留时的积极处理。

关 键 词:非小细胞肺癌  联合化疗  多西他赛  

Observation of Therapeutic Effect of Chemotherapy Combined with Docetaxel and Cisplatin for Advanced Non-small Cell Lung Cancer
Zhang Lai-sha,Chu Jina-hua.Observation of Therapeutic Effect of Chemotherapy Combined with Docetaxel and Cisplatin for Advanced Non-small Cell Lung Cancer[J].Journal of Yangtze University,2009,6(3):90-91.
Authors:Zhang Lai-sha  Chu Jina-hua
Institution:Department of pharmacy;the General Hospital of Jianghan Oil Field;Qianjiang 433124;China
Abstract:Objective:To explore efficacy,toxicity and side effects of chemotherapy combined with docetaxel plus cisplatin in the treatment of advanced non-small cell lung cancer(NSCLC),Methods:17untreated patients whih advanced NSCLC diagnosed by pathology or cytology were received docetaxel plus cisplatin(the DP group).The TP group with 26 patients received paclitaxel plus cisplatin,(the DP group).The efficacy was estimated after 2 cycles of chemotherapy.Results:The overall response rate(CR+PR) was 42.2% in the TP gr...
Keywords:Non-small cell lung cancer  Combined chemotherapy  Cisplatin  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号